好文档 - 专业文书写作范文服务资料分享网站

布地奈德混悬液异丙托溴铵和硫酸沙丁胺醇溶液联合雾化吸入治疗 AE

天下 分享 时间: 加入收藏 我要投稿 点赞

布地奈德混悬液异丙托溴铵和硫酸沙丁胺醇溶液联合雾化

吸入治疗 AECOPD 临床观察

李蕾

【期刊名称】《河北医学》 【年(卷),期】2014(000)003

【摘要】目的:探讨布地奈德混悬液联合吸入用异丙托溴铵和硫酸沙丁胺醇溶液(复方异丙托溴胺溶液)雾化吸入治疗急性加重期慢性阻塞性肺部疾病(AECOPD)的临床价值。方法:选取我院2009年1月至2011年12月我院收治的AECOPD患者110例,随机分为两组,分别采用吸入用异丙托溴铵和硫酸沙丁胺醇溶液雾化吸入和布地奈德混悬液联合雾化吸入治疗。结果:研究组患者咳嗽症状消失时间相比对照组无显著性差异(P>0.05),喘憋、湿啰音、哮鸣音消失时间与住院时间相比对照组均明显减少(P<0.05)。两组患者治疗前PEF、PaO2、PaCO2、呼吸困难评分比较无明显差异(P>0.05),治疗后研究组组患者PEF、PaO2、PaCO2、呼吸困难评分均较治疗前明显改善(P<0.05),治疗后研究组PEF、PaO2、PaCO2、呼吸困难评分相比对照组有明显改善( P<0.05)。结论:吸入用异丙托溴铵和硫酸沙丁胺醇溶液联合布地奈德混悬液相比单用复方异丙托溴胺溶液雾化吸入治疗AECOPD能够有效缩短临床症状与体征消失时间、住院时间,明显改善呼吸功能情况。%Objective:To investigate the clinical value of budesonide suspension combined inhalation of supporting bromide and salbutamol sulfate solution with isopropyl ( compound ipratropium bromide solution ) inhalation in the treatment of acute exacerbation of chronic

obstructive pulmonary disease ( AECOPD ) . Method:110 patients with AECOPD in our hospital from 2009 January to 2011 December were selected , they were randomly divided into two groups , They were respectively treated by inhalation of ipratropium bro-mide and salbutamol sulfate solution and atomization inhalation of budesonide suspension combined inhalation therapy .Result:The cough symptoms disappeared time of the research group had no significant difference compared with control group (P >0.05), while, wheezing, wet rales, wheeze disappeared time of the re-search group significantly reduced (P<0.05).Before treatment, PEF, PaO2, PaCO2, dyspnea scores of two groups of patients showed in significant difference (P>0.05), after treatment PEF, PaO2 group, PaCO2, dyspnea scores of research group were significantly improved (P<0.05), PEF, PaO2, PaCO2, dyspnea score of research group were obviously improved comparing with the control group (P<0.05).Conclusion:Inhalation of ipratropium bromide and salbutamol sulfate solution combined with budesonide suspension com -paring with the single compound ipratropium bromide solution for inhalation in the treatment of AECOPD can effectively shorten the clinical symptoms and signs disappeared time , hospitalization time , and improve re-spiratory function . 【总页数】3页(420-422)

【关键词】联合雾化吸入;AECOPD;布地奈德;异丙托溴铵;硫酸沙丁胺醇

【作者】李蕾

【作者单位】北京市朝阳区第二医院急诊科,北京 朝阳区 100026 【正文语种】中文 【中图分类】 【文献来源】

https://www.zhangqiaokeyan.com/academic-journal-cn_hebei-medicine_thesis/0201247226630.html 【相关文献】

1.吸入用复方异丙托溴氨溶液、吸入用布地奈德混悬液、硫酸沙丁胺醇雾化吸入溶液三联雾化治疗小儿喘息性疾病的临床效果研究 [J], 张宏

2.布地奈德混悬液联合硫酸沙丁胺醇、异丙托溴铵雾化吸入治疗喘息性支气管炎疗效观察 [J], 卢慧; 郁凌飞

3.硫酸沙丁胺醇联合不同剂量布地奈德混悬液雾化吸入治疗AECOPD合并肺部感染的临床观察 [J], 杨杰文; 洪浚娜; 方佳; 薛峰; 金伟勋

4.布地奈德混悬液联合异丙托溴铵溶液雾化吸入治疗慢性阻塞性肺气肿的临床疗效及护理效果观察 [J], 郝玉英; 张文珍

5.用硫酸沙丁胺醇溶液和布地奈德混悬液氧气驱动雾化吸入疗法治疗毛细支气管炎的疗效观察 [J], 李剑

以上内容为文献基本信息,获取文献全文请下载

布地奈德混悬液异丙托溴铵和硫酸沙丁胺醇溶液联合雾化吸入治疗 AE

布地奈德混悬液异丙托溴铵和硫酸沙丁胺醇溶液联合雾化吸入治疗AECOPD临床观察李蕾【期刊名称】《河北医学》【年(卷),期】2014(000)003【摘要】目的:探讨布地奈德混悬液联合吸入用异丙托溴铵和硫酸沙丁胺醇溶液(复方异丙托溴胺溶液)雾化吸入治疗急性加重期慢性阻塞性肺部疾病(AECOPD)的临床价值。方法:
推荐度:
点击下载文档文档为doc格式
2brdh2ifxz9acj39qpyw5s23r4b08q00ep1
领取福利

微信扫码领取福利

微信扫码分享